JERSEY CITY, N.J.--(BUSINESS WIRE)--Oct 22, 2023--Today, Celltrion USA announced that the U.S. Food and Drug Administration (FDA) has approved ZYMFENTRA 庐 (infliximab-dyyb) for maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) and Crohn鈥檚 disease (CD) ...
HELSINKI (AP) 鈥� Norway鈥檚 86-year-old <a href="https://apnews.com/article/norway-king-harald-hospital-infection-bb00c1712b9e9e426409a215a189a569">King Harald V,</a> who has been in frail health in the past few years, has tested positive for the coronavirus and has ...
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Oct 22, 2023--Updated results from a subgroup analysis of a first-in-human <a ...
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Oct 22, 2023--Updated results from the <a ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Oct 22, 2023--<a ...
RAHWAY, N.J.--(BUSINESS WIRE)--Oct 21, 2023--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the Phase 3 LITESPARK-005 trial investigating WELIREG, Merck鈥檚 first-in-class, oral hypoxia-inducible factor-2 alpha (HIF-2a) inhibitor, for the ...
